Transiciones en contexto: hallazgos vinculados a migración rural-urbana y enfermedades no transmisibles en Perú

Miranda, J. Jaime; Wells, Jonathan C. K.; Smeeth, Liam

doi:10.1590/s1726-46342012000300012

Cited by 13 publications

(11 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Los resultados demográficos de la población estudiada muestran un rango bastante amplio en las edades que refieren presentar una de estas tres enfermedades cróni-cas ( hipertensión, diabetes y cáncer) desde 18 a 90 años de edad, aspecto que llama la atención pues, en la literatura revisada hasta el momento, se reporta edades con mayor prevalencia de enfermedades crónicas a partir de los 40 a más años de edad (6,7,25); así mismo, cabe señalar que el mayor porcentaje reportado con diagnóstico de cáncer es en el grupo de 18 a 39 años de edad en comparación con los de 40 a más años, aunque el presente estudio no tuvo por finalidad medir prevalencias de enfermedades crónicas, estos resultados podrían estar sugiriendo realizar investigaciones de estudio de prevalencia en jó-venes.…”

Section: Discussionunclassified

“…Los estimados correspondientes en cada grupo para obesidad, también en un patrón de gradiente, fueron 3; 20 y 33%. La hipertensión arterial presenta alrededor del 11 al 15%, mientras que es el doble, casi 30%, en la población urbana; estas diferencias fueron notorias también según sexo en el grupo de migrantes (6). Es reconocido por el Ministerio de Salud como un problema de salud pública y se identifica, al menos, cuatro enfermedades crónicas prioritarias: hipertensión, diabetes, obesidad y cáncer (7).…”

Section: Introductionunclassified

See 1 more Smart Citation

El automanejo de enfermedades crónicas: población de una jurisdicción de centros de salud

Córdova¹,

Vergel-Camacho²,

Lezama-Vigo³

et al. 2015

Rev enferm Herediana.

View full text Add to dashboard Cite

Section: Discussionunclassified

Section: Introductionunclassified

El automanejo de enfermedades crónicas: población de una jurisdicción de centros de salud

Córdova¹,

Vergel-Camacho²,

Lezama-Vigo³

et al. 2015

Rev enferm Herediana.

View full text Add to dashboard Cite

“…Each country is at a different stage in the epidemiological transition. Its burden of NCDs is influenced by the demographic composition of its population, its exposure to risk factors, its stage in the nutritional and epidemiological transitions, its geography and its ability to provide effective health care [61]. For example, smoking-related disease may be less in some countries because of cultural barriers to smoking and limited penetration by tobacco corporations.…”

Section: Discussionmentioning

confidence: 99%

Towards a comprehensive global approach to prevention and control of NCDs

et al. 2014

View full text Add to dashboard Cite

BackgroundThe “25×25” strategy to tackle the global challenge of non-communicable diseases takes a traditional approach, concentrating on a few diseases and their immediate risk factors.DiscussionWe propose elements of a comprehensive strategy to address NCDs that takes account of the evolving social, economic, environmental and health care contexts, while developing mechanisms to respond effectively to local patterns of disease. Principles that underpin the comprehensive strategy include: (a) a balance between measures that address health at the individual and population level; (b) the need to identify evidence-based feasible and effective approaches tailored to low and middle income countries rather than exporting questionable strategies developed in high income countries; (c) developing primary health care as a universal framework to support prevention and treatment; (d) ensuring the ability to respond in real time to the complex adaptive behaviours of the global food, tobacco, alcohol and transport industries; (e) integrating evidence-based, cost-effective, and affordable approaches within the post-2015 sustainable development agenda; (f) determination of a set of priorities based on the NCD burden within each country, taking account of what it can afford, including the level of available development assistance; and (g) change from a universal “one-size fits all” approach of relatively simple prevention oriented approaches to more comprehensive multi-sectoral and development-oriented approaches which address both health systems and the determinants of NCD risk factors.SummaryThe 25×25 is approach is absolutely necessary but insufficient to tackle the the NCD disease burden of mortality and morbidity. A more comprehensive approach is recommended.

show abstract

“…In a world where life expectancy is increasing, how to sustain ideal cardiovascular health across the lifespan [59] and for longer periods over the lifecourse of individuals, and populations, remains pivotal to accrue future larger gains in reducing morbidity and mortality. This is more evident in low- and middle-income countries characterized by contrasting settings with persistent inequality, where poverty will contribute to and impact on demographic and epidemiological transitions [35,60–62]. For example, what primary prevention interventions might work, in the long run, in countries where obesity in early years is increasingly common as in emerging economies or in countries transitioning from low-to middle-income status?…”

Section: Challenges For Global Health Cardiologymentioning

confidence: 99%

Global Shifts in Cardiovascular Disease, the Epidemiologic Transition, and Other Contributing Factors

Mendoza¹,

Miranda

2017

Cardiology Clinics

Self Cite

View full text Add to dashboard Cite

One of the major drivers of change in the practice of cardiology, in both developed and developing countries, is population change, whose dynamics can be expressed by secular epidemiological and demographic trends, with increasing survival and life expectancy across all age strata. The sole concept of transition, whether epidemiological or demographic, is quite dynamic. From a global health point of view, one element merits attention: developed countries have had longer time to double or triple their population, usually more than one century, whereas the same increases in population size in the developing world occurred just over decades. The epidemiological transition theory, far from being perfect, introduced a booster to the understanding of the changing dynamics of epidemiological profiles and provided a complement to the discourse of the demographic change. In this article, with an special emphasis on the challenges faced by low- and middle-income settings, we describe current debates of the epidemiological transition paired with other ongoing transitions with direct relevance to cardiovascular conditions. Challenges specific to patterns of risk factors over time; readiness for disease surveillance and meeting global targets; health systems, prevention and treatment efforts; and physiological traits and human-environment interactions are identified. These challenges provide also an opportunity to redefine the agenda of global health cardiology and global cardiovascular research. This article concludes that a focus on the most populated regions of the world, who bear the highest disease burden related to cardiovascular conditions, will contribute substantially to protect the large gains in global survival and life expectancy accrued over the last decades. It then follows that a renewed workforce in global health cardiology must swiftly adapt to these changing environments. As the world changes, the practice of cardiology, clinical cardiology, global health cardiology and cardiology research will follow suit.

show abstract

Transiciones en contexto: hallazgos vinculados a migración rural-urbana y enfermedades no transmisibles en Perú

Cited by 13 publications

References 36 publications

El automanejo de enfermedades crónicas: población de una jurisdicción de centros de salud

El automanejo de enfermedades crónicas: población de una jurisdicción de centros de salud

Towards a comprehensive global approach to prevention and control of NCDs

Global Shifts in Cardiovascular Disease, the Epidemiologic Transition, and Other Contributing Factors

Contact Info

Product

Resources

About